Grady Grant III Nacd.
Board of Directors Compensation & Audit Committees Compliance Financial Reporting @Aptevo Therapeutics Inc
Signup · Get unlimited contacts
WORK HISTORY
Board of Directors Compensation & Audit Committees Compliance Financial Reporting @Aptevo Therapeutics Inc
I provide critical guidance on commercial business execution and sale of commercial assets to fund biotech organization focused on bringing novel oncology therapeutic options to market. I navigate the financial reporting process via leveraging internal controls and compliance for start-up company spun off from Emergent Bioscience. I also oversee executive compensation and assess performance measures against set goals/objectives.
EDUCATION
Northwestern University - Kellogg School of Management
Corporate Governance
Duke University
Executive Education Program
Temple University School of Pharmacy
B.S. Pharmacy, Pharmaceutical Science
ABOUT GRADY GRANT III NACD.
BOARD PROFILEMr. Grant brings to the Board a prolific background of executive leadership integrating the execution of medical and consumer brands. He offers expertise in sales operations, business development strategies and transformational leadership. Six Sigma Green Belt and graduate of Temple University School of Pharmacy, holding certification in General Management from Duke University. Completed Executive Education in Corporate Governance from Northwestern University, Kellogg School of Business. Board leadership includes serving on Nominating & Governance, Audit and Compensation Committees.Holistic business leader known for building high-performance teams through transforming sales organizations across 10 distinct therapeutic areas in prominent medical companies including Eli Lilly and Mead Johnson.Trusted advisor currently serving on private board in multiple capacities for $32M biotech company, Aptevo Therapeutics, providing sales and marketing insight to CEO while leveraging internal controls and compliance.Diversity & inclusion advocate who reshaped organizational culture for $240M operation with salesforce and $6B P&L.PUBLIC COMPANY BOARD EXPERIENCEAPTEVO Therapeutics (NYSE: APVO)$32M biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.Preside over financial reporting process, leveraging internal controls and compliance for start-up company spun off from Emergent BioScience. Oversee executive compensation and assess performance against established goals and objectives.Member of Compensation Committee (2016 – Present)Member of Audit Committee (2016 – Present)Member of Nominating and Corporate Governance Committee (2016 – Present)PRIVATE COMPANY BOARD EXPERIENCETemple University, School of PharmacyPublic research university in Philadelphia, Pennsylvania with roughly undergraduate, graduate and professional students.A champion for fundraising initiatives, selected and solicited funds from probate industry for Pharmacy School Centennial.> Board of Visitors Committee (2016)Urban LeagueNonpartisan historic civil rights organization based in New York City that advocates on behalf of economic and social justice for African Americans and against racial discrimination in the United States.Served as Executive Leader from Eli Lilly, leading community outreach efforts.> Board Member (2011)Indiana Blood Bank (Versiti Blood Center of Central Indiana)National leader in innovative blood health solutions.Marketing Committee (1998)
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.